Get complete Patent Opposition Report for Syndax Pharmaceuticals

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore Syndax Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP3270966May 1, 2024Combination Of Hdac Inhibitor And Anti-Pd-1 Antibody For Treatment Of Cancer2
EP2751267Jan 24, 2018Methods For The Treatment Of Breast Cancer2